Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-052627

Chief Medical Officer sold 6,000 shares at $65.00 ($390,000)

  • Chief Medical Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bowden Christopher Chief Medical Officer 2017-09-11 Option exercise +6,000 $35.16 $210,960 6,881 D: show line 1 in the form
Bowden Christopher Chief Medical Officer 2017-09-11 Sale −6,000 $65.00 $390,000 881 D: show line 2 in the form
Open-market sales · 6,000 sh · avg $65.00 · $390,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bowden Christopher Chief Medical Officer 2017-09-11 Option exercise · Stock option (right to buy) −6,000 109,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…